Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiahua He

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cancer Treatment and Research Communications|January 15, 2026
Corrigendum to: Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis: Cancer Treatment and Research Communications 46 (2026) 101059Song Wang, Jiahua He, Yuanbin Liao, et al.
Cancer Treatment and Research Communications|December 12, 2025
Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasisSong Wang, Jiahua He, Yuanbin Liao, et al.
Annals of Medicine|September 9, 2024
Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasisWeihao Li, Jin Lan, Chi Zhou, et al.
Gastroenterology Report|June 30, 2025
circNRIP1 impairs tumorigenesis of colorectal cancer by sponging IGF2BP1 and decreasing <i>NACC1</i> mRNA stabilityKai Han, Qiaoqi Sui, Yanbo Xu, et al.
Aging Cell|September 16, 2021
Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patientsHaitao Yu, Yanchao Liu, Ting He, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 12, 2024
MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastasesJiahua He, Weihao Li, Jiayu Wang, et al.
Autophagy|August 24, 2023
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancerWeihao Li, Chi Zhou, Long Yu, et al.
Cancer Research|March 5, 2026
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-Enhancer FormationWeihao Li, Jianhong Peng, Jiahua He, et al.
Clinical and Translational Medicine|January 3, 2026
Feedback regulation between histone H3 lysine 18 lactylation and TROP2-mediated glycolysis drives metastatic progression of colorectal cancerWeifeng Wang, Yuxiang Deng, Weihao Li, et al.
Cancer Letters|July 19, 2025
Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancerJiahua He, Weihao Li, Song Wang, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer Treatment and Research Communications|January 15, 2026
Corrigendum to: Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis: Cancer Treatment and Research Communications 46 (2026) 101059Song Wang, Jiahua He, Yuanbin Liao, et al.
Cancer Treatment and Research Communications|December 12, 2025
Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasisSong Wang, Jiahua He, Yuanbin Liao, et al.
Annals of Medicine|September 9, 2024
Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasisWeihao Li, Jin Lan, Chi Zhou, et al.
Gastroenterology Report|June 30, 2025
circNRIP1 impairs tumorigenesis of colorectal cancer by sponging IGF2BP1 and decreasing <i>NACC1</i> mRNA stabilityKai Han, Qiaoqi Sui, Yanbo Xu, et al.
Aging Cell|September 16, 2021
Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patientsHaitao Yu, Yanchao Liu, Ting He, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 12, 2024
MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastasesJiahua He, Weihao Li, Jiayu Wang, et al.
Autophagy|August 24, 2023
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancerWeihao Li, Chi Zhou, Long Yu, et al.
Cancer Research|March 5, 2026
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-Enhancer FormationWeihao Li, Jianhong Peng, Jiahua He, et al.
Clinical and Translational Medicine|January 3, 2026
Feedback regulation between histone H3 lysine 18 lactylation and TROP2-mediated glycolysis drives metastatic progression of colorectal cancerWeifeng Wang, Yuxiang Deng, Weihao Li, et al.
Cancer Letters|July 19, 2025
Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancerJiahua He, Weihao Li, Song Wang, et al.
Pageof 6